FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first treatment for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On December 20, the FDA announced that it has approved Eli Lilly's Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in obese adults. The FDA noted that the drug should be combined […]
FDA approves first medication for obstructive sleep apnea, promotes weight loss
The first treatment for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On December 20, the FDA announced that it has approved Eli Lilly's Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in obese adults. The FDA noted that the drug should be combined […]
Costco-brand cold and flu medication recalled by FDA: Here’s what to know
Thousands of Costco-branded cold and flu medicines have been pulled from shelves. A total of 8,640 boxes of Kirkland Severe Cold and Flu Plus Crowded Daypacks and Nightpacks were recalled by the Food and Drug Administration (FDA) last week. This follows the FDA's proposal in early November to ban the use of oral phenylephrine as […]
New medication for ALS eligible for fast-track FDA approval
Researchers say new hope could be on the horizon for ALS patients in the form of a “groundbreaking” drug. Nuvivo, a California biopharmaceutical company developing treatments for neurodegenerative diseases, is seeking approval for a new drug for amyotrophic lateral sclerosis (ALS). According to the ALS Association, ALS is a progressive neurodegenerative disease that gradually impairs […]
Aging slowdown could be surprise benefit of existing medication, research shows
Join Fox News for access to this content Plus, your account will give you exclusive access to select articles and other premium content for free. Enter your email address[続行]By pressing , you agree to Fox News' Terms of Use and Privacy Policy, including notice of financial incentives. Please enter a valid email address. Need help? […]
FDA approves new class of medication for schizophrenia patients
A new drug has been approved to treat schizophrenia in adults. On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral drug manufactured by Bristol-Myers Squibb of New Jersey. According to a press release, this is the first new class of treatment for brain disorders in decades. 5 […]
Reforming 340B vital for affordable medication for low-income patients
Time 340B Drug Pricing Program Established in 1992, the program was intended by Congress to help low-income and uninsured patients afford prescription drugs. Pharmaceutical companies that make drugs covered by Medicaid are required to participate in the program, which offers them to patients at a discount that averages 25 to 50 percent off the wholesale […]
Physicians Charged in Matthew Perry’s Death Can Still Prescribe Medication
Two doctors indicted for their love affairs friend Doctors are reportedly still allowed to prescribe the drug following the death of star Matthew Perry. Doctors Mark Chavez and Salvador Plascencia, who are accused of conspiring to supply Perry with ketamine, said they could prescribe the drug to any patient just as they did to the […]
Diabetes patients have access to first generic GLP-1 medication: ‘More accessible’
Ozempic, Wegovy and other GLP-1 drugs have been shown to reduce weight and Diabetes Management Demand has skyrocketed in recent years, making it difficult for some people to obtain the medicine. To clear up supply chain disruptions, the first-ever generic GLP-1, a replica of Victoza, was launched on June 25th. Victoza, manufactured by Novo Nordisk […]
Record numbers in England taking ADHD medication, NHS data shows | Attention deficit hyperactivity disorder
Record numbers of people in England are taking medication for ADHD, data shows, highlighting a surge in diagnoses. According to the latest NHS Business Services data, around 278,000 patients in England were prescribed central nervous system stimulants (CNS) and attention deficit hyperactivity disorder (ADHD) medications between April 2023 and March 2024. That equates to about […]